We continue to monitor the fluid situation regarding the novel coronavirus, SARS-CoV-2, and want to bring you the latest information.
United Kingdom Prime Minister Boris Johnson has ordered closure of all non-essential businesses effective March 23, 2020. The Government will look again at these measures in three weeks, and relax them if the evidence shows this is possible.
As an essential business, Myoderm continues to operate its facilities in both the United Kingdom and the United States so your sites have the drugs and ancillary supplies they need for the patients in your trials.
As we have stated before, we will be in rapid contact with you should we receive any information that impacts your trials. We appreciate the trust you place in us and want you to feel confident that we continue to earn it.
If you have specific concerns about supplies for your trial, your Myoderm representative will be happy to answer your questions.